EXJADE

Medicinal product

(Invented) name

EXJADE

Active substance (s)

Deferaziroksas

Strength

360 mg

Pharmaceutical form

granulės paketėlyje

Route (s) of administration

vartoti į burną ir ryklę

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

V03AC03, Deferasirox

Marketing authorisation holder

Novartis Europharm Ltd., Airija

Date of authorisation

2006-08-28

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Granules in sachet	1 vnt.
Deferaziroksas	360 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
98336	84438	1084438	paketėlis	N30		Receptinis	EU/1/06/356/022	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2006-08-28	Registruotas